BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Prognosis
56 results:

  • 1. Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma.
    He J; Yin H; Xia Y; Wu JZ; Liang JH; Zhu HY; Fan L; Li JY; Wang L; Xu W
    Leuk Res; 2021 Nov; 110():106664. PubMed ID: 34271293
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole-body muscle magnetic resonance imaging in patients with muscle symptoms: incidental findings and outcomes.
    Claeys KG; Goosens V
    Eur J Neurol; 2021 Jan; 28(1):323-330. PubMed ID: 32892468
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.
    Borchmann S; Joffe E; Moskowitz CH; Zelenetz AD; Noy A; Portlock CS; Gerecitano JF; Batlevi CL; Caron PC; Drullinsky P; Hamilton A; Hamlin PA; Horwitz SM; Kumar A; Matasar MJ; Moskowitz AJ; Owens CN; Palomba ML; Younes A; Straus DJ
    Blood; 2019 May; 133(20):2121-2129. PubMed ID: 30770396
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic lymphoma.
    Ammann EM; Shanafelt TD; Larson MC; Wright KB; McDowell BD; Link BK; Chrischilles EA
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e11-e25. PubMed ID: 28802891
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Role of eukaryotic translation initiation factor 4G in tumor].
    Zhang S; Huang N; Pan X; Zang JL; Guan XX; Zhang JH; Liu LC; Lei XY
    Sheng Li Xue Bao; 2016 Apr; 68(2):207-14. PubMed ID: 27108909
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.
    Horvilleur E; Sbarrato T; Hill K; Spriggs RV; Screen M; Goodrem PJ; Sawicka K; Chaplin LC; Touriol C; Packham G; Potter KN; Dirnhofer S; Tzankov A; Dyer MJ; Bushell M; MacFarlane M; Willis AE
    Leukemia; 2014 May; 28(5):1092-102. PubMed ID: 24135829
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients.
    Roland V; Bodet-Milin C; Moreau A; Gastinne T; Mahé B; Dubruille V; Maisonneuve H; Juge-Morineau N; Moreau P; Jardel H; Planche L; Mohty M; Moreau P; Harousseau JL; Kraeber-Bodéré F; Le Gouill S
    Bone Marrow Transplant; 2011 Mar; 46(3):393-9. PubMed ID: 20577223
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term study of indolent adult T-cell leukemia-lymphoma.
    Takasaki Y; Iwanaga M; Imaizumi Y; Tawara M; Joh T; Kohno T; Yamada Y; Kamihira S; Ikeda S; Miyazaki Y; Tomonaga M; Tsukasaki K
    Blood; 2010 Jun; 115(22):4337-43. PubMed ID: 20348391
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinicopathologic study of 15 splenectomy specimens of patients with hairy cell leukemia].
    Li ZQ; Chen HS; Liu EB; Sun Q; Fang LH; Sun FJ; Zhang PH; Yang QY; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):769-73. PubMed ID: 20079018
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland.
    Olivier KR; Brown PD; Stafford SL; Ansell SM; Martenson JA
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1510-4. PubMed ID: 15590182
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Coexistence of pregnancy and cancer.
    Jacobs IA; Chang CK; Salti GI
    Am Surg; 2004 Nov; 70(11):1025-9. PubMed ID: 15586520
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A helping computer system prognosing the survival of patients with Hodgkin's disease.
    Mateva NG; Nenova IS; Georgieva IG; Shtraklina NT; Doikova AD
    Folia Med (Plovdiv); 2003; 45(2):30-3. PubMed ID: 12943055
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Very long survival in pediatric cancer between 1944 and 1993.
    Zhao G; Boysen CD; Brown EF; Hassanein KM; Holmes FF; Holmes GE
    Chin Med J (Engl); 1999 Jul; 112(7):615-9. PubMed ID: 11601255
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Primary hepatic lymphoma: favorable outcome after combination chemotherapy.
    Page RD; Romaguera JE; Osborne B; Medeiros LJ; Rodriguez J; North L; Sanz-Rodriguez C; Cabanillas F
    Cancer; 2001 Oct; 92(8):2023-9. PubMed ID: 11596015
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
    Wilson LD; Jones GW; Kim D; Rosenthal D; Christensen IR; Edelson RL; Heald PW; Kacinski BM
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristine, cyclophosphamide, bleomycin and prednisone): 25-year experience.
    Bellesi G; Rigacci L; Longo G; Alterini R; Bernardi F; Messori A; Trippoli S; Vaiani M; Carrai V; Rossi Ferrini P
    Oncol Rep; 2000; 7(4):891-6. PubMed ID: 10854565
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Second malignancies after Hodgkin's disease: the Munich experience.
    Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
    Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Favorable prognosis after late relapse of Hodgkin's disease.
    Garcia-Carbonero R; Paz-Ares L; Arcediano A; Lahuerta J; Bartolome A; Cortes-Funes H
    Cancer; 1998 Aug; 83(3):560-5. PubMed ID: 9690550
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Acute lymphoblastic leukemia with severe skeletal involvement: a subset of childhood leukemia with a good prognosis.
    Müller HL; Horwitz AE; Kühl J
    Pediatr Hematol Oncol; 1998; 15(2):121-33. PubMed ID: 9592839
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.